🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A protocol named as "HLH-DR" for patients with refractory and secondary hem...
Status
Unknown
Location
Yan Yue
Start Date
2017-03-01
Trial ID
NCT03795909
Treatments Being Tested
This is a single centre, open-label, randomised, single dose, three-period,...
Status
Completed
Location
Simbec Research Ltd.
Start Date
2017-05-22
Trial ID
NCT03178214
Treatments Being Tested
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
Radiation therapy is the main treatment for nasopharyngeal carcinoma (NPC),...
Status
Recruiting
Location
Affiliated Hospital of Guangdong Medical University
Start Date
2022-08-15
Trial ID
NCT07327216
Treatments Being Tested
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested